Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 4:10 pm Purchase | 2023-02-03 | 13G | AVALO THERAPEUTICS INC AVTX | Great Point Partners, LLC | 4,061 7.120% | 4,061 (New Position) | Filing History |
| 2022-12-01 4:03 pm Purchase | 2022-11-21 | 13G | OPTINOSE INC OPTN | Great Point Partners, LLC | 754,315 9.990% | 754,315 (New Position) | Filing History |
| 2022-09-30 09:37 am Purchase | 2022-09-21 | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Great Point Partners, LLC | 3,448,521 7.850% | 3,448,521 (New Position) | Filing History |
| 2022-07-08 5:13 pm Purchase | 2022-06-29 | 13G | 89BIO INC ETNB | Great Point Partners, LLC | 2,100,000 5.290% | 2,100,000 (New Position) | Filing History |
| 2022-07-01 2:35 pm Purchase | 2022-06-22 | 13G | PRECISION BIOSCIENCES INC DTIL | Great Point Partners, LLC | 191,847 5.890% | 191,847 (New Position) | Filing History |
| 2022-05-18 4:03 pm Purchase | 2022-05-09 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Great Point Partners, LLC | 1,280,000 5.220% | 1,280,000 (New Position) | Filing History |
| 2022-02-14 11:23 am Sale | 2021-12-31 | 13G | INFLARX N V COM IFRX | Great Point Partners, LLC | 0 0.000% | -4,400,000 (Position Closed) | Filing History |